• HRC2019
  • 6 - 9 Oct 2019, The ICC, Birmingham UK

Prof Max Hilz

Max Hilz

Position: Head of Clinical Dept. of Autonomic Neurology
Location: Erlangen DE

Studied medicine in Cologne and Erlangen-Nuremberg, Germany. After initial training in Anesthesiology and Intensive Care Medicine and in Ear-Nose-and–Throat diseases, he trained in Neurology and Psychiatry at the University of Erlangen-Nuremberg.

He specialized in Neurology, Clinical Neurophysiology, Neurological Intensive Care Medicine and Disorders of the Autonomic Nervous System (ANS). He holds German board certificates in Neurology and Psychiatry and in Psychotherapy. He also passed the board examination of the American Board of Electrodiagnostic Medicine. He is licensed to practice medicine in Germany, the United Kingdom, and in the State of New York, USA.

From 1992 until 2013, he held appointments at New York University, New York, NY, as Professor of Neurology, Medicine and Psychiatry. Until 2007, he also served as the Associate Director of the NYU Dysautonomia Evaluation and Treatment Center. He was deeply involved in clinical research regarding the pathophysiology of Familial Dysautonomia, also known as Riley-Day syndrome or Hereditary Sensory and Autonomic Neuropathy Type III, and in studies of Fabry disease.

He is Professor of Neurology at the University of Erlangen-Nuremberg in Erlangen, Germany. Since June 2015, he is also Adjunct Professor of Neurology at Icahn School of Medicine at Mount Sinai, New York, NY, USA.  From September 1, 2016 to August 31, 2017, he was the Chair in Autonomic Neurology, and Director of the Clinical Department of Autonomic Neurology at the University College London, Institute of Neurology, Queen Square, London, UK.

Professor Hilz currently co-chairs the Autonomic Nervous System Subspecialty Panel of the European Academy of Neurology, EAN. He also is Past-President of the German Autonomic Society, Past-President of the European Federation of Autonomic Societies, and Past-Chair of the Autonomic Section of the American Academy of Neurology. He is a member of the editorial board of Clinical Autonomic Research, and Associate Clinical Editor of Autonomic Neuroscience: Basic and Clinical. He published more than 300 original and review articles in peer-reviewed journals and chapters in textbooks and presented his work at several hundred scientific conferences. He wrote textbook chapters on basic and sophisticated methods of autonomic testing, and co-authored various autonomic nervous system guidelines and consensus statements, e.g. the guidelines of the German Neurological Society on syncope, the guidelines on erectile dysfunction, the guidelines of the German Diabetes Society on diabetic neuropathy, the consensus statement of the American Academy of Neurology and the American Autonomic Society on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome, as well as the EFNS guidelines on the diagnosis and management of orthostatic hypotension. He served on the expert panel that developed the Autonomic Nervous System subspecialty examination of the American Academy of Neurology. He also served as an advisor to the European Medicines Agency, EMA, on issues related to autonomic nervous system dysfunction. Among his many invited lectures is a teaching course on the differential diagnosis of transient loss of consciousness.

In summary, Prof. Hilz is experienced in the examination of small nerve fiber diseases and disorders of the autonomic nervous system, including hereditary sensory and autonomic neuropathies, diabetic neuropathies, and Fabry disease, and central autonomic disorders.

Sign up to receive the latest updates